Evotec SE (EVOTF) EBITDA (2020 - 2025)

Evotec SE's (EVOTF) quarterly EBITDA came in at $67514.5 in Q4 2025, up 121.69% year-on-year from $30455.0 in Q4 2024, and up 229.77% quarter-over-quarter from -$52025.3 in Q3 2025.

Evotec SE (EVOTF) EBITDA (2020 - 2025) Analysis & Trends

Evotec SE has disclosed EBITDA across 6 years of filings, most recently posting $67514.5 for Q4 2025.

  • EBITDA for Q4 2025 came in at $67514.5, up 121.69% year-over-year; the trailing twelve-month figure through Dec 2025 was $16849.1 (down 75.46% YoY), and the FY2025 annual result was $61927.1, up 156.42% from the prior year.
  • EBITDA came in at $67514.5 for Q4 2025 at Evotec SE, up from -$52025.3 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $80176.3 in Q4 2021 to a low of -$52025.3 in Q3 2025.
  • The 5-year median for EBITDA is $20918.2 (2021), against an average of $16621.2.
  • Across the five-year window, EBITDA slumped 882.27% in 2023 and surged 121.69% in 2025, its largest moves.
  • Evotec SE's EBITDA stood at $80176.3 in 2021, then slumped by 43.25% to $45503.0 in 2022, then rose by 18.73% to $54024.0 in 2023, then plunged by 43.63% to $30455.0 in 2024, then jumped by 121.69% to $67514.5 in 2025.
  • The last three EBITDA figures came in at $67514.5 (Q4 2025), -$52025.3 (Q3 2025), and $30455.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 652.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 833.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 325.80 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -681,231.97
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 185.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 307.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -67.29 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 81.33 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -98.81 Mn
10 Evotec SE - - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 67,514.52
Sep 30, 2025 -52,025.29
Dec 31, 2024 30,454.97
Sep 30, 2024 -29,095.13
Dec 31, 2023 54,024.02
Sep 30, 2023 13,266.65
Jun 30, 2023 -39,514.89
Dec 31, 2022 45,503.03
Sep 30, 2022 13,640.94
Jun 30, 2022 -4,022.80
Mar 31, 2022 21,169.53
Dec 31, 2021 80,176.35
Sep 30, 2021 20,918.20
Jun 30, 2021 1,850.97
Mar 31, 2021 25,457.61
Dec 31, 2020 127,123.14
Sep 30, 2020 19,120.26